Swiss Nordic Bio Zürich 25 January 2022
| Reference number | |
| Coordinator | Lucero AB |
| Funding from Vinnova | SEK 14 000 |
| Project duration | December 2021 - January 2022 |
| Status | Completed |
Important results from the project
The Swiss Nordic Bio conference will help us to expedite the validation of our product-market fit, we plan to have 1-1 meetings with future customers from relevant Swiss pharmaceutical companies
Expected long term effects
It gives us a great opportunity to get everyone in the same place to talk about Lucero’s technology and have discussions with multiple companies simultaneously around what functionalities they would need to see from our product to consider a future pilot project with us.
Approach and implementation
This conference will help us to expedite the validation of our product-market fit, the meetings will be with future customers from relevant Swiss pharmaceutical companies